Orexo appoints Peter Edman CSO
This article was originally published in Scrip
Executive Summary
Orexo, a pharma company developing pain and inflammation treatments, has appointed Dr Peter Edman chief scientific officer, effective 1 January 2012. Dr Edman has been CSO and head of R&D at Swedish Orphan Biovitrum since 2008, and previously served at Pharmacia, Swedish Medical Product Agency and AstraZeneca.